News | December 23, 2022
Strides Pharma Global receives AUD 94 mn for sale of Australia's operations
The balance of AUD 94 Million was a deferred consideration backed by a secured interest-bearing instrument
The balance of AUD 94 Million was a deferred consideration backed by a secured interest-bearing instrument
As per the agreement, NSE-listed Vaishali Pharma Limited will take over the entire domestic and international marketing of Jark Pharma’s portfolio of quality based ayurvedic products
Allam was serving recently as the CEO at Public Investment Fund
According to IQVIA sales data for the 12-month period ending October 2022, the Cardene Capsules, 20 mg and 30 mg market achieved annual sales of approximately US $10.9 million
None of the observations are related to data integrity and management believes that they are addressable
The Halol facility was placed under Import Alert by USFDA.
The company will submit an action plan on the observations and will engage with US FDA for next steps.
The acquisition marks JB Pharma’s entry into the ‘Statin’ segment which is the largest group in the cardiac therapy
Implants from the U.S. startup Allay Therapeutics are designed to relieve pain after knee surgery for up to three weeks
This one-of-a-kind ophthalmic subspecialty division is focused on the treatment of the eye condition glaucoma
Subscribe To Our Newsletter & Stay Updated
